Prescription Required
Ryzodeg Penfill 3ml is an innovative insulin product designed for the effective management of diabetes mellitus. Combining two types of insulin provides both rapid-acting and long-acting effects, ensuring better glycemic control throughout the day. Manufactured by Novo Nordisk, Ryzodeg is a trusted choice for patients and healthcare professionals worldwide.
Limit consumption as it can cause unpredictable blood sugar levels.
Consult your doctor for insulin dose adjustments during pregnancy.
Discuss insulin management with your healthcare provider if you are breastfeeding.
Be aware of hypoglycemia symptoms while driving; check blood sugar levels regularly.
Notify your doctor about any kidney problems for personalized insulin dosage adjustments.
Inform your doctor about any liver issues for personalized insulin dosage adjustments.
Ryzodeg contains: Insulin Aspart (Rapid-acting): Quickly reduces blood sugar levels after meals. Insulin degludec (Long-acting): Provides a steady insulin supply for up to 24 hours, minimizing blood sugar fluctuations. Together, these components regulate blood glucose levels effectively, reducing the risk of hyperglycemia and hypoglycemia.
Diabetes mellitus is a chronic condition where the body cannot effectively regulate blood sugar levels. It occurs due to insufficient insulin production (Type 1) or insulin resistance (Type 2). Symptoms include increased thirst, frequent urination, fatigue, and weight loss.
RYZODEG Penfill 3ml is a dual-action insulin that simplifies diabetes management by combining fast and long-acting effects. With fewer injections and steady glucose control, it ensures convenience and efficacy for diabetic patients.
Content Updated on
Tuesday, 8 April, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA